PMN insider transaction filings

ProMIS Neurosciences Inc. — 41 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen PMN transaction legs live →

FiledFormInsiderReported transactionsSource
2026-08-074Kaplan Johanne — Chief Development OfficerPurchase (P): 2,280 @ $13.30EDGAR
2026-05-224Williams Eugene — DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2026-05-224Warma Neil K — Chief Executive Officer, DirectorGrant/award (A): 160,000 (derivative) @ $0EDGAR
2026-05-224Shafmaster Madge K. — DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2026-05-224Cashman Neil — Chief Scientific Officer, DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-05-224Milbury Max A. — Principal Accounting OfficerGrant/award (A): 18,167 (derivative) @ $0EDGAR
2026-05-224Mandel-Brehm Josh — DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2026-05-224Kaplan Johanne — Chief Development OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-05-224Alex Slanix Paul — DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2026-05-224WYMAN WILLIAM W — DirectorGrant/award (A): 5,500 (derivative) @ $0 · Grant/award (A): 11,000 (derivative) @ $0EDGAR
2026-04-234Kirwin Patrick D. — DirectorPurchase (P): 4,000 @ $11.33EDGAR
2026-03-064Williams Eugene — DirectorPurchase (P): 2,000 @ $24.40EDGAR
2026-03-044Williams Eugene — DirectorPurchase (P): 1,000 @ $22.53 · Purchase (P): 1,000 @ $21.89 · Purchase (P): 2,000 @ $24EDGAR
2026-02-234Kaplan Johanne — Chief Development OfficerPurchase (P): 1,629 @ $15.35EDGAR
2026-02-054ABG Management Ltd. — 10% owner
Ally Bridge MedAlpha Master Fund L.P. — 10% owner
Ally Bridge Group (NY) LLC — 10% owner
Yu Fan — 10% owner
Alex Slanix Paul — Director
Purchase (P): 700,741 @ $12.13 · Purchase (P): 700,741 (derivative)EDGAR
2026-02-054Cashman Neil — Chief Scientific Officer, DirectorGrant/award (A): 4,122 @ $12.13 · Grant/award (A): 4,122 (derivative)EDGAR
2026-02-054Kaplan Johanne — Chief Development OfficerGrant/award (A): 2,060 @ $12.13 · Grant/award (A): 2,060 (derivative)EDGAR
2026-02-054Warma Neil K — Chief Executive Officer, DirectorGrant/award (A): 6,183 @ $12.13 · Grant/award (A): 6,183 (derivative)EDGAR
2026-02-054Milbury Max A.Grant/award (A): 6,595 @ $12.13 · Grant/award (A): 6,595 (derivative)EDGAR
2026-02-054Kirwin Patrick D. — DirectorGrant/award (A): 3,050 @ $12.13 · Grant/award (A): 3,050 (derivative)EDGAR
2025-10-244ABG Management Ltd. — 10% owner
Ally Bridge MedAlpha Master Fund L.P. — 10% owner
Ally Bridge Group (NY) LLC — 10% owner
Yu Fan — 10% owner
Alex Slanix Paul — Director
Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-10-064Milbury Max A.Purchase (P): 30,392 @ $0.49EDGAR
2025-09-304Jeremy M. Sclar 2012 Irrevocable Family Trust — 10% ownerOption exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · +1 moreEDGAR
2025-09-244Kaplan Johanne — Chief Development OfficerGrant/award (A): 165,000 (derivative) @ $0EDGAR
2025-09-244Cashman Neil — Chief Scientific Officer, DirectorGrant/award (A): 165,000 (derivative) @ $0EDGAR
2025-09-244Milbury Max A.Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-09-244ALTSTIEL LARRY DOUGLAS — Chief Medical OfficerGrant/award (A): 165,000 (derivative) @ $0EDGAR
2025-09-244Warma Neil K — Chief Executive Officer, DirectorGrant/award (A): 600,000 (derivative) @ $0EDGAR
2025-09-084Sclar Jeremy M. — 10% ownerOption exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · Option exercise/expiry (X): 697,674 (derivative) @ $0 · +1 moreEDGAR
2025-08-144/ATitle 19 PromisOption exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0EDGAR
2025-08-144GORDON MICHAEL SOther (J): 48,333EDGAR
2025-08-144/AGORDON MICHAEL SOption exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0EDGAR
2025-07-294Title 19 Promis — 10% ownerOption exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · +1 moreEDGAR
2025-07-294GORDON MICHAEL S — 10% ownerOption exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · Option exercise/expiry (X): 119,800 (derivative) @ $0 · +1 moreEDGAR
2025-07-024GORDON MICHAEL S — 10% ownerSale (S): 93,223EDGAR
2025-06-164Mandel-Brehm Josh — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-164Kirwin Patrick D. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-164Shafmaster Madge K. — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-164Williams Eugene — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-06-164WYMAN WILLIAM W — DirectorGrant/award (A): 20,000 (derivative) @ $0EDGAR
2025-02-124Cashman Neil — Chief Scientific Officer, DirectorPurchase (P): 15,000 @ $0.97EDGAR

Recent 8-K events — ProMIS Neurosciences Inc.

FiledFormItems reportedSource
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-288-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-258-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-308-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-168-K8.01 — Other EventsEDGAR
2025-11-248-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-198-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2025-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PMN returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →